CXC chemokine receptor 4 (CXCR4) blockade in cancer treatment
Shunshun BaoThe First Clinical Medical College, Xuzhou Medical University, 221000, Xuzhou, ChinaMohammad DarvishiInfectious Diseases and Tropical Medicine Research Center (IDTMRC), Department of Aerospace and Subaquatic Medicine, AJA University of Medicinal Sciences, Tehran, IranAli H. AminDeanship of Scientific Research, Umm Al-Qura University, 21955, Makkah, Saudi ArabiaMaysoon Al‐HaideriDepartment of Physiotherapy, Cihan University-Erbil, Erbil, Kurdistan Region, IraqIndrajit PatraAn Independent Researcher, National Institute of Technology Durgapur, Durgapur, West Bengal, IndiaKhadisha KashikovaKazakh-Russian National Medical University, Almaty, KazakhstanIrfan AhmadDepartment of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, Abha, Saudi ArabiaFahad AlsaikhanCollege of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, Saudi ArabiaZahraa Haleem Al‐qaimMoaed E. Al‐GazallyCollege of Medicine, University of Al-Ameed, Karbala, IraqBahman Abedi KiasariVirology Department, Faculty of Veterinary Medicine, The University of Tehran, Tehran, Iran. [email protected]Bahareh Tavakoli‐FarDepartment of Physiology and Pharmacology, Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran. [email protected]Akmal A. SidikovRector, Ferghana Medical Institute of Public Health, Ferghana, UzbekistanYasser Fakri MustafaDepartment of Pharmaceutical Chemistry, College of Pharmacy, University of Mosul, Mosul, 41001, IraqReza Akhavan‐SigariDepartment of Health Care Management and Clinical Research, Collegium Humanum Warsaw Management University, Warsaw, Poland
ABI
Аннотация
Аннотация отсутствует.